Clinical Trial Update: A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy, pharmacokinetics, safety and tolerability of flexible doses of intranasal esketamine plus an oral antidepressant in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine (intranasal) (esketamine)
• Oral antidepressant (unspecified)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Treatment-Resistant | Phase 3 | Status: COMPLETED | Results posted: 2022-05-24